Key Takeaways
- Up to 50% of patients don't download prescribed digital health apps or engage with them actively
- Poor adoption rates significantly limit the effectiveness of digital treatments for chronic conditions like fibromyalgia
- Researchers are testing different onboarding strategies to improve patient engagement with self-monitoring apps
A striking 50% of chronic musculoskeletal pain patients prescribed digital health applications never download them or fail to engage meaningfully with the technology. This sobering statistic has prompted researchers to examine how different onboarding strategies might bridge the gap between prescription and active use. The challenge is particularly acute for conditions like fibromyalgia, where consistent self-monitoring and management could significantly improve patient outcomes.
Up to half of patients do not download prescribed digital health applications or actively engage with them
This represents a major barrier to digital healthcare effectiveness in chronic disease management
The research focuses on a self-monitoring and management app designed for chronic musculoskeletal pain conditions. Digital health applications offer promising avenues for continuous care management, allowing patients to track symptoms, medication use, and pain levels between clinical visits. However, the technology's potential remains largely untapped when adoption rates hover around 50%, creating what researchers describe as a critical bottleneck in digital therapeutic delivery.
The disconnect between prescription and usage represents more than a technology problem—it reflects a fundamental challenge in chronic care delivery. Like prescribing a medication that patients never pick up from the pharmacy, digital health tools cannot demonstrate their effectiveness if they remain unused. This adoption gap undermines the growing investment in digital therapeutics, which market analysts project will reach billions in value over the next decade.
Chronic musculoskeletal pain conditions, including fibromyalgia, affect millions of patients who could benefit from consistent symptom tracking and self-management tools. These conditions often fluctuate unpredictably, making regular monitoring between appointments particularly valuable for both patients and healthcare providers. Yet the 50% non-adoption rate suggests that current approaches to introducing these tools fall short of patient needs and expectations.
The prospective study examining different onboarding strategies represents a crucial step toward understanding how to translate clinical prescriptions into active patient engagement. As healthcare systems increasingly integrate digital therapeutics into standard care protocols, addressing these adoption barriers could significantly impact treatment outcomes for millions of patients living with persistent pain conditions.
Impact of Different Onboarding Strategies on Low Adoption and Engagement With a Self-Monitoring and Management App for Chronic Musculoskeletal Pain: Prospective Study.
Medical Disclaimer: The information provided on ChronicRelief.org is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.